Interventions for Tuberculosis Control and Elimination 2002

15. Goldman AL, Braman SS.
Chest 1972; 62: 71-7.
Isoniazid: a review with emphasis on adverse effects.
16. Knowles S, Uetrecht J, Shear NH. Idiosyncratic drug reactions: the reactive
metabolite syndromes. Lancet 2000; 356: 1587-91.
17. Meyer H, Mally J. Über Hydrazinderivate der Pyridincarbonsäuren. Monatshefte
für Chemie und verwandte Teile anderer Wissenschaften 1912; 23: 393-414.
18. Domagk G, Offe HA, Siefken W. Ein weiterer Beitrag zur experimentellen
Chemotherapie der Tuberkulose (Neoteben). Deutsch Med Wschr 1952; 77: 573-8.
19. Benson WM, Stefko PL, Roe MD. Pharmacologic and toxicologic observations
on hydrazine derivatives of isonictoinic acid (RimifonTM , MarsilidTM ).
Tuberc 1952; 65: 376-91.
Am Rev
20. Bernstein J, Lott WA, Steinberg BA, Yale HL. Chemotherapy of experimental
tuberculosis. V. Isonicotinic acid hydrazide (NydrazidTM ) and related compounds.
Am Rev Tuberc 1952; 65: 357-64.
21. Suo J, Chang CR, Lin TP, Heifets LB. Minimal inhibitory concentrations of isoniazid,
rifampin, ethambutol, and streptomycin against Mycobacterium tuberculosis
strains isolated before treatment of patients in Taiwan.
1988; 138: 999-1001.
Am Rev Respir Dis
22. Inderlied CB, Salfinger M. Antimicrobial agents and susceptibility tests: mycobacteria.
In: Murray PR, Baron EJ, Pfaller MA, Tenover FC, Yolken RH, Eds. Manual
of clinical microbiology. Washington DC: ASM Press, 1995; 1385-1404.
23. Lee CN, Heifets B. Determination of minimal inhibitory concentrations of antituberculosis
drugs by radiometric and conventional methods.
1987; 136: 349-52.
Am Rev Respir Dis
24. Jindani A, Aber VR, Edwards EA, Mitchison DA. The early bactericidal activity
of drugs in patients with pulmonary tuberculosis.
121: 939-49.
Am Rev Respir Dis 1980;
25. Jindani A. The effect of single and multiple drugs on the viable count of M. tuberculosis
in the sputum of patients with pulmonary tuberculosis during the early days
of treatment. Thesis, University of London, 1979.
26. Hafner R, Cohn JA, Wright DJ, Dunlap NE, Egorin MJ, Enama ME, Muth K,
Peloquin CA, Mor N, Heifets LB, DATRI 008 Study Group. Early bactericidal
activity of isoniazid in pulmonary tuberculosis.
Am J Respir Crit Care Med 1997; 156: 918-23.
Optimization of methodology.
27. Sirgel FA, Donald PR, Odhiambo J, Githui W, Umapathy KC, Paramasivan CN,
Tam CM, Kam KM, Lam CW, Sole KM, Mitchison DA. A multicentre study of
the early bactericidal activity of anti-tuberculosis drugs.
2000; 45: 859-70.
J Antimicrob Chemother
28. World Health Organization. A concurrent comparison of home and sanatorium
treatment of pulmonary tuberculosis in South India.
1959; 21: 51-144.
Bull World Health Organ
172